CureVac NV (CVAC)
4.66
0.00 (0.00%)
USD |
NASDAQ |
Jun 10, 16:00
CureVac Shareholders Equity (Quarterly) : 1.024B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 1.024B |
| June 30, 2025 | 688.31M |
| March 31, 2025 | 698.55M |
| December 31, 2024 | 721.34M |
| September 30, 2024 | 808.80M |
| June 30, 2024 | 403.55M |
| March 31, 2024 | 482.67M |
| December 31, 2023 | 571.04M |
| September 30, 2023 | 637.65M |
| June 30, 2023 | 708.11M |
| March 31, 2023 | 775.07M |
| December 31, 2022 | 569.11M |
| Date | Value |
|---|---|
| September 30, 2022 | 612.27M |
| June 30, 2022 | 651.53M |
| March 31, 2022 | 750.88M |
| December 31, 2021 | 782.93M |
| September 30, 2021 | 805.81M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 870.37M |
| September 30, 2020 | 892.80M |
| June 30, 2020 | |
| March 31, 2020 | -47.90M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| PAION AG | -- |
| Epigenomics AG | -- |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alkermes Plc | 1.752B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.338B |
| Total Liabilities (Quarterly) | 314.18M |
| Debt to Equity Ratio | 0.0403 |
| Current Ratio | 3.697 |
| Net Debt Paydown Yield | 0.01% |